NASDAQ · DRMA

Dermata Therapeutics, Inc.

Closing price · Nov 13, 2026 $0.6212
Last insider buy price $1.27 Paid by SVP, Regulatory Affairs Munera Bedoya-Toro on Feb 17, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 10, 2026
Revenue growth
—Sales for the quarter: $74.1K
Gross marginSteady
54.1%
Quarter ended Sep 30, 2026: 54.1% gross margin
Sep '26Sep '26
Cash from operationsWorse
−$2.65M
Quarter ended Dec 31, 2024: −$2.91M cash from operationsQuarter ended Mar 31, 2025: −$1.93M cash from operationsQuarter ended Jun 30, 2025: −$2.69M cash from operationsQuarter ended Sep 30, 2025: −$1.8M cash from operationsQuarter ended Dec 31, 2025: −$1.37M cash from operationsQuarter ended Mar 31, 2026: −$2.48M cash from operationsQuarter ended Jun 30, 2026: −$2.42M cash from operationsQuarter ended Sep 30, 2026: −$2.65M cash from operations
Dec '24Sep '26
vs. −$1.8M a year ago
Share countDiluting
+380.3%
Quarter ended Dec 31, 2024: 5.43M sharesQuarter ended Mar 31, 2025: 6.38M sharesQuarter ended Jun 30, 2025: 681,557 sharesQuarter ended Sep 30, 2025: 1.03M sharesQuarter ended Dec 31, 2025: 4.02M sharesQuarter ended Mar 31, 2026: 4.02M sharesQuarter ended Jun 30, 2026: 4.02M sharesQuarter ended Sep 30, 2026: 4.93M shares
Dec '24Sep '26
4.93M shares vs. 1.03M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    1 real insider sale in 12 months. $13 in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

13 funds report owning DRMA, up from 7

Holdings as of Jun 30, 2026
New7
Added1
Held3
Trimmed2
Sold out1

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Dec 23 · 612,745 shStock grant · Dec 23 · 122,549 shStock grant · Aug 16 · 170,068 shStock grant · Aug 16 · 102,040 shOpen-market buy · Feb 17 · $1.27KOpen-market sale · Jun 16 · $13
CEOCFOOther officersDirectorsJunJulAugSepOctNovStock grant · Aug 16 · 170,068 shStock grant · Aug 16 · 102,040 shOpen-market sale · Jun 16 · $13

Last 6 months. A wider screen shows 12.

Showing 2 real trades. Hidden: 4 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Jun 16 Kathleen Scott Director Open-market sale $13 11 sh at $1.19 Sold 100% of stake
Feb 17 Munera Bedoya-Toro SVP, Regulatory Affairs Open-market buy $1.27K 1,000 sh at $1.27

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in DRMA

As of Jun 30, 2026
FundOwnsValueChange
Geode Capital Management, LLC0.4%$26.1K−58%
Welch & Forbes LLC0.4%$25.8KSame
State Street Corp0.4%$24.2KNew
UBS Group AG0.3%$21.7K−53%
Susquehanna International Group, LLP0.3%$20.6KNew

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast